Zhejiang East Asia Pharmaceutical Co., Ltd. (SHA:605177)
China · Delayed Price · Currency is CNY 24.89
+0.19 (0.77%)
Sep 23, 2026, 3:00 PM CST
SHA:605177 Financials Overview
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 990.47 | 940.19 | 1,198 | 1,356 | 1,180 | 712.22 |
Revenue Growth | 2.55% | -21.54% | -11.66% | 15.00% | 65.62% | -19.22% |
Gross Profit Gross Profit Growth | 122.22 | 176.37 | 194.21 | 348.75 | 266.06 | 190.6 |
Operating Income Operating Income Growth | -169.2 | -87.23 | -109.91 | 111.84 | 88.52 | 32.79 |
Net Income Net Income Growth | -170.54 | -82.39 | -100.66 | 121.25 | 104.43 | 68.49 |
Earnings Per Share EPS Growth | -1.50 | -0.72 | -0.90 | 0.97 | 0.92 | 0.60 |
EPS Growth | - | - | - | 5.44% | 53.33% | -54.20% |
| Fiscal Year | FY 2025 |
|---|---|
| Period Ending | Dec '25 Dec 31, 2025 |
ß-lactam antibiotics ß-lactam antibiotics Growth | 481.76 |
Anticholinergics and Synthetic Antispasmodics Anticholinergics and Synthetic Antispasmodics Growth | 197.1 |
Quinolones Antibiotics Quinolones Antibiotics Growth | 108.3 |
Antifungal drugs for skin Antifungal drugs for skin Growth | 71.61 |
Other Products Other Products Growth | 47.43 |
Total Total Growth | 906.19 |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 399.71 | 448.89 | 581.01 | 889.03 | 531.58 | 606.1 |
Total Debt Total Debt Growth | 916.35 | 994.2 | 793.06 | 706.93 | 122.76 | 2.38 |
Net Cash (Debt) Net Cash Growth | -516.63 | -545.31 | -212.05 | 182.1 | 408.82 | 603.72 |
Net Cash Growth | - | - | - | -55.46% | -32.28% | -38.36% |
Net Cash Per Share Net Cash Per Share Growth | -4.54 | -4.77 | -1.90 | 1.46 | 3.60 | 5.29 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | 20.3 | -268.86 | -156.55 | -84.06 | -70.35 | -23.6 |
Capital Expenditures CapEx Growth | -44.71 | -74.26 | -211.61 | -227.47 | -87.82 | -121.97 |
Free Cash Flow Free Cash Flow Growth | -24.42 | -343.11 | -368.16 | -311.53 | -158.17 | -145.57 |
Free Cash Flow Growth | - | - | - | - | - | - |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Gross Margin | 12.34% | 18.76% | 16.21% | 25.71% | 22.56% | 26.76% |
Operating Margin | -17.08% | -9.28% | -9.17% | 8.24% | 7.51% | 4.60% |
Pretax Margin | -18.23% | -9.42% | -9.86% | 9.93% | 9.76% | 10.82% |
Profit Margin | -17.22% | -8.76% | -8.40% | 8.94% | 8.85% | 9.62% |
FCF Margin | -2.46% | -36.49% | -30.73% | -22.97% | -13.41% | -20.44% |
| Fiscal Year | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|
| Period Ending | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Dividend Per Share Dividend Per Share Growth | 0.327 | 0.290 | 0.200 |
Dividend Per Share Growth | 12.63% | 45.00% | -42.86% |
Dividend Yield | 1.25% | 1.49% | 0.75% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 23, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | - | - | - | 24.81 | 21.78 | 45.84 |
Forward PE | - | 8.48 | 10.15 | 18.20 | - | - |
PS Ratio | 2.83 | 2.13 | 1.85 | 2.22 | 1.93 | 4.41 |